Kisspeptin-10 Shows Dual Power Against Brain Inflammation and Cellular Damage

Neuroinflammation, characterized by chronic activation of immune cells in the brain, is a critical factor in the progression of many neurodegenerative diseases like Alzheimer's and Parkinson's. A key driver of this inflammation is the NLRP3 inflammasome, a multi-protein complex that, when activated, triggers pyroptosis (a highly inflammatory form of programmed cell death) and releases pro-inflammatory cytokines. This process exacerbates neuronal damage and contributes to disease pathology. Current therapeutic strategies often target individual inflammatory pathways, but a compound with a dual mechanism could offer broader protection. This study specifically addresses whether Kisspeptin-10 can modulate both NLRP3 inflammasome activation and promote cellular clean-up processes in microglial cells, the brain's primary immune cells.